fren

Part of the Stem Cell Network’s mandate is to support the training of the next generation of more than 4,100 highly qualified personnel (HQP) who will lead and grow Canada’s regenerative medicine sector. It will be innovative early-career investigators, supported by SCN, who will develop new therapies, novel technologies and insightful research to inform policy development.


SCN released a new report entitled: Training Tomorrow’s Research Leadersoutlining the impacts of nearly 20 years of our training program. To learn more about the career paths and employment trends of SCN trainees click here.


Some examples of our programs include:

Exchange Program:
Aims to provide researchers and trainees the opportunity to acquire specific skills or develop collaborations that will directly benefit their research project.
Travel Awards Program:
SCN offers a variety of travel awards to support trainees/HQP to learn and collaborate by enabling them to attend workshops and courses within Canada and internationally.
Bursary Program:
SCN bursaries provide financial assistance for eligible trainees to attend workshops and courses. In most cases, the bursary includes workshop registration fees, travel, hotel and meals costs. 

SCN would like to acknowledge the contributions and support from the Government of Canada, the SCN Training & Education and Trainee Communications Committees and our workshop and event partners, through which these knowledge translation activities have been made possible.

What are stem cells?

Stem cells are our bodies’ building blocks. They are different from other cells because they have the potential to differentiate into any cell type and can renew themselves, which means they can heal blood, tissue and organs.

Read more

In the news

Significant Advancements in SCN-funded Type 1 Diabetes Clinical Trial

December 2, 2021 (Ottawa, ON) – The promising results from a Canadian clinical trial funded by the Stem Cell Network (SCN) represents a significant scientific advancement in treating those who live with type 1 diabetes.  In the first study of its kind, Dr. Timothy Kieffer and his team at the University of British Columbia’s (UBC) …

Read more